Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company CSL Ltd.
DescriptionPlasma-derived injectable powder containing human coagulation Factor VIII and human von Willebrand factor (vWF) complex
Molecular Target Factor VIII
Mechanism of ActionFactor VIII replacement
Therapeutic ModalityBiologic: Protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today